PT-141 10mg

PT-141 Peptide is the research community's shorthand for PT-141 - the same compound listed on this page. If you searched for PT-141 Peptide, PT141, PT 141, Bremelanotide, PT-141 Australia, this is that compound: PT-141 supplied as a 10mg lyophilised vial, third-party tested with a batch-specific Certificate of Analysis. For in-vitro research use only.

PT-141 is a synthetic peptide supplied by Pillar Research as Lyophilised powder for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. In research communities it is also searched for as PT141, PT 141, Bremelanotide, PT-141 Australia - all refer to the same compound.

Studied for how central brain receptors respond in laboratory models. More precisely, a selective derivative of Melanotan II, engineered to act through central melanocortin receptors. PT-141 is supplied strictly as Research Use Only material for in-vitro laboratory work.

Studied in male and female research models. More precisely, sexual arousal and desire, acting through central nervous system melanocortin pathways rather than the vascular mechanisms studied for other compounds used for similar research purposes.

PT-141 is commonly referred to as PT-141 Peptide in research communities and is sometimes searched for as PT141, PT 141, Bremelanotide, PT-141 Australia - all refer to the same compound.

PT-141 (Bremelanotide) is studied as a more selective derivative of Melanotan II, engineered to act through central melanocortin receptors.

You are looking at the evidence the same way researchers do: by compound, batch and method, not by marketing claim. PT-141 is supplied as a research-use compound for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Each Pillar Research batch is third-party tested by HPLC and mass spectrometry, with the batch-specific Certificate of Analysis published for review before ordering - that certificate is the research record to judge.

No. PT-141 is supplied as lyophilised powder in a sealed glass vial for reconstitution with bacteriostatic water, not as a pre-formulated nasal spray. Some suppliers market a nasal-spray format; Pillar Research's listing is the standard injectable-format research vial.

Pillar Research does not provide dosing, reconstitution-for-use, or administration guidance for any compound - this is a deliberate policy, not an oversight, consistent with the Research Use Only framework under which PT-141 is supplied. Research protocols vary by study design and institution. Consult the peer-reviewed literature for the compound (see the references linked on this page) or a qualified research supervisor for protocol-specific guidance.

PT-141 (10mg) is available through Pillar Research, a trusted supplier for research peptides, with fast domestic shipping to all states and territories. Every vial is dispatched from domestic Australian stock the same business day - no customs delays, no international freight uncertainty. The batch-specific Certificate of Analysis is available to review before ordering. See our supplier guide at /buy-peptides-australia for the checklist to apply to any Australian supplier.

Pillar Research does. Each PT-141 batch is tested by Janoshik Analytical, an independent third-party laboratory, and the batch-specific Certificate of Analysis is published on this page before you order. Stock is held in Australia and dispatched with dispatch in an estimated 1-2 weeks.

PT-141 (10mg) is priced at A$89.99 per vial at Pillar Research. PT-141 is open for preorder now. Orders dispatch in an estimated 1-2 weeks. Batch Certificates of Analysis are available in our CoA library.

PT-141 is a research-use compound supplied for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Purchasers confirm the compound is intended for in-vitro research use at checkout.

Ordering is straightforward - add PT-141 10mg (PT-141 Peptide) to your cart on this page and complete checkout. All orders are fulfilled from domestic Australian stock and shipped with tracking; dispatch in an estimated 1-2 weeks. A batch-specific Certificate of Analysis is included with every order.

Yes. Each released PT-141 10mg (PT-141 Peptide) vial is linked to a batch-specific Certificate of Analysis (COA) so the stated purity, identity and batch record can be reviewed before ordering. PT-141 10mg (PT-141 Peptide) is listed at 99.924% purity. Each released batch is independently analysed by HPLC for chromatographic purity and by mass spectrometry for identity.

Yes. PT-141 (Bremelanotide) has been studied in human clinical research in male and female participants - a deeper evidence base than compounds studied only in preclinical models. Pillar Research supplies it strictly as Research Use Only material for in-vitro laboratory work.

Sildenafil and tadalafil are approved medicines acting through vascular (PDE5) pathways. PT-141 is an investigational research compound acting through central melanocortin pathways - a different compound class, studied for different mechanisms. Pillar Research supplies PT-141 only as Research Use Only material for in-vitro laboratory research.

No. PT-141 is not listed on the Australian Register of Therapeutic Goods (ARTG), so it is not stocked by Australian retail pharmacies and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Compounding pharmacies cannot supply it either - there is no approved commercial or pharmacy release to compound from. Pillar Research supplies it as Research Use Only material for in-vitro laboratory work, not for human or animal use, and it should not be sought as a consumer product.

PT-141 may be lawfully supplied and held in Australia as Research Use Only material for in-vitro laboratory and educational research. That is a different status from approval for human use, which it does not have. Purchasers confirm they are a qualified researcher or acting for a licensed research facility, and are responsible for the lawful handling, storage and use of the material.